Dionne Maude, Sauvageau Chantal, Etienne Doriane, Witteman Holly O, Dubé Ève
Institut national de santé publique du Québec, Québec, Canada.
Centre de recherche du CHU de Québec-Université Laval, Québec, Canada.
Prev Med Rep. 2024 Nov 19;48:102931. doi: 10.1016/j.pmedr.2024.102931. eCollection 2024 Dec.
Human papillomavirus (HPV) vaccines have been offered in Quebec schools to 4th-grade (9-10 years old) girls since 2008 and boys since 2016. HPV vaccine coverage does not reach the 90 % target in many regions. This project evaluated the feasibility and the acceptability of interventions to improve HPV vaccine acceptability and coverage in school-based programs.
The evaluation was conducted in 32 Quebec schools in 2019-2020. We tested a strategy of three interventions implemented in sequence (face-to-face information session, email reminder with an online decision support tool, and telephone reminder using motivational interviewing (MI) techniques). Parents and school staff completed online surveys. School nurses participated in individual interviews. Key stakeholders participated in a workshop to identify enabling conditions and barriers to implementing interventions across Quebec.
The strategy was generally well-received by school staff, nurses, and parents. Many parents found the 3 interventions helpful to support their vaccination decision. Most parents (92 %) suggested that the face-to-face information session and the decision support tool (82 %) be offered to all parents. Nevertheless, delivering classroom presentations was perceived by nurses as logistically challenging. Parents were generally satisfied with the telephone reminder, but only a limited number of nurses applied motivational interviewing techniques, as half (51 %) of unreturned consent forms were due to forgetfulness.
Our strategy was accepted and deemed feasible by a majority of parents, school staff, and nurses. Collaboration between health authorities and schools is essential for implementing interventions to enhance vaccine acceptance in school-based programs.
自2008年起,魁北克省的学校就开始为四年级(9至10岁)女孩提供人乳头瘤病毒(HPV)疫苗,自2016年起也为男孩提供该疫苗。在许多地区,HPV疫苗接种率未达到90%的目标。本项目评估了在学校项目中提高HPV疫苗可接受性和接种率的干预措施的可行性和可接受性。
2019年至2020年在魁北克省的32所学校进行了评估。我们测试了一种依次实施三种干预措施的策略(面对面信息交流会、带有在线决策支持工具的电子邮件提醒以及使用动机性访谈(MI)技巧的电话提醒)。家长和学校工作人员完成了在线调查。学校护士参与了个人访谈。关键利益相关者参加了一个研讨会,以确定在魁北克省实施干预措施的有利条件和障碍。
该策略总体上受到学校工作人员、护士和家长的好评。许多家长发现这三种干预措施有助于支持他们的疫苗接种决定。大多数家长(92%)建议向所有家长提供面对面信息交流会和决策支持工具(82%)。然而,护士们认为在课堂上进行展示在后勤方面具有挑战性。家长们总体上对电话提醒感到满意,但只有少数护士应用了动机性访谈技巧,因为未返还的同意书中有一半(51%)是由于遗忘。
我们的策略被大多数家长、学校工作人员和护士接受并认为是可行的。卫生当局和学校之间的合作对于在学校项目中实施提高疫苗接受度的干预措施至关重要。